A detailed history of Entry Point Capital, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 11,215 shares of FLGT stock, worth $205,683. This represents 0.14% of its overall portfolio holdings.

Number of Shares
11,215
Holding current value
$205,683
% of portfolio
0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$19.6 - $25.06 $219,814 - $281,047
11,215 New
11,215 $243,000
Q1 2024

May 14, 2024

BUY
$21.55 - $29.29 $334,434 - $454,551
15,519 Added 15066.99%
15,622 $339 Million
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $2,434 - $3,117
103 New
103 $2.98 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $555M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.